Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Intravenous Immunoglobulin Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the prevalence of chronic inflammatory demyelinating polyneuropathy (CIDP) and hypogammaglobulinemia
5.1.1.2. Significant rise in geriatric population and number of hemophilic patients
5.1.1.3. Rising use of off-label indications in intravenous immunoglobulin products
5.1.2. Restraints
5.1.2.1. Stringent government regulations toward the use of intravenous immunoglobulin products
5.1.3. Opportunities
5.1.3.1. Emergence of improved technologies in immunoglobulin production
5.1.3.2. Increasing number of intravenous immunoglobulin product approvals
5.1.4. Challenges
5.1.4.1. High risk of side effects associated with intravenous immunoglobulin products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Intravenous Immunoglobulin Market, by Indication
6.1. Introduction
6.2. Primary Immunodeficiency
6.3. Secondary Immunodeficiency

7. Intravenous Immunoglobulin Market, by Form
7.1. Introduction
7.2. Liquid IVIG
7.3. Lyophilized IVIG

8. Intravenous Immunoglobulin Market, by End-User
8.1. Introduction
8.2. Homecare Facilities
8.3. Hospitals & Clinics

9. Americas Intravenous Immunoglobulin Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Intravenous Immunoglobulin Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Intravenous Immunoglobulin Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. ADMA Biologics, Inc.
13.1.2. Baxter International, Inc.
13.1.3. Bayer HealthCare LLC
13.1.4. Biotest AG by Grifols S.A.
13.1.5. CSL Behring
13.1.6. Johnson & Johnson Services, Inc.
13.1.7. Kedrion S.p.A.
13.1.8. LFB Biotechnologies
13.1.9. Octapharma AG
13.1.10. Option Care Health, Inc.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. INTRAVENOUS IMMUNOGLOBULIN MARKET RESEARCH PROCESS
FIGURE 2. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, 2023 VS 2030
FIGURE 3. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INTRAVENOUS IMMUNOGLOBULIN MARKET DYNAMICS
FIGURE 7. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. INTRAVENOUS IMMUNOGLOBULIN MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. INTRAVENOUS IMMUNOGLOBULIN MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. INTRAVENOUS IMMUNOGLOBULIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 9. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY LIQUID IVIG, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY LYOPHILIZED IVIG, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 12. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY HOMECARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. CANADA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. CANADA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 26. CANADA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. MEXICO INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. MEXICO INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 29. MEXICO INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. CHINA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. CHINA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. CHINA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. INDIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. INDIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. INDIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. INDONESIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. JAPAN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. JAPAN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 52. JAPAN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. MALAYSIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. PHILIPPINES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. SINGAPORE INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. SOUTH KOREA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. TAIWAN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. THAILAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. THAILAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 70. THAILAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. VIETNAM INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. DENMARK INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. DENMARK INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 80. DENMARK INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. EGYPT INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. EGYPT INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. EGYPT INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. FINLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. FINLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. FINLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. FRANCE INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. FRANCE INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 89. FRANCE INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. GERMANY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. GERMANY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 92. GERMANY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. ISRAEL INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ITALY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. ITALY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. ITALY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. NIGERIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NORWAY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. NORWAY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 107. NORWAY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. POLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. POLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 110. POLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. QATAR INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. QATAR INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 113. QATAR INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SPAIN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. SPAIN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 125. SPAIN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SWEDEN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SWITZERLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. TURKEY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. TURKEY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 134. TURKEY INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. INTRAVENOUS IMMUNOGLOBULIN MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 142. INTRAVENOUS IMMUNOGLOBULIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 143. INTRAVENOUS IMMUNOGLOBULIN MARKET LICENSE & PRICING